The biotech sector has held up better than one would expect during the carnage and volatility in the markets over the past couple of months. The lows this sector made in mid-June have formed a firm fl...
The biotech sector has held up better than one would expect during the carnage and volatility in the markets over the past couple of months. The lows this sector made in mid-June have formed a firm fl...